Factors influencing uptake of human papillomavirus vaccine among school-going adolescent girls (10-14 years) in Kibra Sub County, Nairobi City County, Kenya
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250603Abstract
Background: The human papillomavirus (HPV) vaccine, which is administered to young girls prior to the initiation of sexual activity, is a crucial primary preventive measure against cervical cancer. Cervical cancer is the primary cause of cancer death and the most common cancer among Kenyan women. The study aimed to assess factors Influencing uptake of human papillomavirus vaccine among school-going adolescent girls (10-14yrs) in Kibra Sub County, Nairobi City County, Kenya.
Methods: The study used an analytical cross-sectional where both qualitative and quantitative data were obtained for triangulation purposes. Both chi-square and binary logistic regression were employed to determine the association between the independent and dependent variables. Qualitative data was analyzed thematically.
Results: The uptake of the HPV vaccine in this study was 29.9% which is a public health concern. Attending a private school (OR=2,95%CI=1.17-3.26), having guardians aged between 34-40 years (OR=4.7,95%CI=0.09-0.53), having a positive perception of the HPV vaccine (OR=2.4,95%CI=0.26-0.66) and easy access to HPV vaccination services (OR=2.7,95%CI=0.22-0.65) increased the odds of the HPV vaccine uptake. Study respondents' guardians who had a primary level of education (OR=4,95%CI=1.97-8.04), being Muslim (OR=1.9,95%CI=0.30-0.94), and the absence of HPV vaccination programs targeting school-going girls (OR=2.2,95%CI=1.36-3.46) reduced the odds of HPV vaccine uptake.
Conclusions: The uptake of the HPV vaccine was suboptimal. Attending a private school, easy access to HPV vaccination services, having guardians aged between 34-40 years, and having a positive perception of the HPV vaccine increased the odds of the HPV vaccine uptake. Multifaceted efforts should be put in place to enhance the uptake of HPV vaccines.
Metrics
References
Beyen MW, Bulto GA, Chaka EE, Debelo BT, Roga EY, Wakgari N, et al. Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020. PLoS One. 2022;17(7):e0271237.
Patel H, Jeve YB, Sherman SM, Moss EL. Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm Infect. 2016;92(6):474-9. DOI: https://doi.org/10.1136/sextrans-2015-052341
Hull1 R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle.income countries (Review). Oncol Lett. 2020;20(3):2058-74. DOI: https://doi.org/10.3892/ol.2020.11754
World Health Organization. Human Papillomavirus (HPV) vaccination coverage, 2024. Available at: https://immunizationdata.who.int/global/wiise-detail-page/human-papillomavirus-(hpv)-vaccination-coverage. Accessed 01 December 2024.
Karanja-Chege CM. HPV vaccination in Kenya: the challenges faced and strategies to increase uptake. Front Public Heal. 2022;10:802947. DOI: https://doi.org/10.3389/fpubh.2022.802947
Kamolratanakul S, Pitisuttithum P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vacci. 2021;9(12):1413. DOI: https://doi.org/10.3390/vaccines9121413
Asgedom YS, Kebede TM, Seifu BL, Mare KU, Asmare ZA, Asebe HA, et al. Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis. Hum Vaccin Immunother. 2024;20(1):2326295.
Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019;15(1):146-55. DOI: https://doi.org/10.1080/21645515.2018.1512453
Restivo V, Costantino C, Fazio TF, Casuccio N, D’Angelo C, Vitale F, et al. Factors associated with HPV vaccine refusal among young adult women after ten years of vaccine implementation. Int J Environ Res Public Health. 2018;15(4):770. DOI: https://doi.org/10.3390/ijerph15040770
Vermandere H, Naanyu V, Mabeya H, Broeck D Vanden, Michielsen K, Degomme O. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One. 2014;9(10):e109353. DOI: https://doi.org/10.1371/journal.pone.0109353
World Health Organization. WHO updates recommendations on HPV vaccination schedule, 2022. Available at: https://www.who.int/news/item/20-12-2022-WHO-updates-recommendations-on-HPV-vaccination-schedule. Accessed 01 December 2024.
Ng’Ang’A A, Nyangasi M, Nkonge NG, Gathitu E, Kibachio J, Gichangi P, et al. Predictors of cervical cancer screening among Kenyan women: results of a nested case-control study in a nationally representative survey. BMC Public Health. 2018;18(Suppl 3):1-10. DOI: https://doi.org/10.1186/s12889-018-6054-9
Kenya National Bureau Statistics. 2019 Kenya Population and Housing Census: Volume II. 2019. Available at: https://housingfinanceafrica.org/app/uploads/VOLUME-II-KPHC-2019.pdf. Accessed 01 December 2024.
Dawud A, Kera AM, Bekele D, Hiko D, Zewdie A. Factors associated with uptake of human papillomavirus vaccination among adolescent girls in Mettu town, southwest Ethiopia: a school-based cross-sectional study. BMJ Open. 2023;13(11):e071878. DOI: https://doi.org/10.1136/bmjopen-2023-071878
Martin I. Factors influencing uptake of human papilloma virus (hpv) vaccine among parents of adolescent girls. Theses Diss. 2022. Available at: https://ecommons.aku.edu/theses_dissertations/198. Accessed 20 June 2024.
Azuogu B, Umeokonkwo C, Azuogu V, Onwe O, Okedo-Alex I, Egbuji C. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria. Niger J Clin Pract. 2019;22(9):1286-91. DOI: https://doi.org/10.4103/njcp.njcp_452_18
Elenwo C, Batioja K, Davis T, Greiner BH, Markey C, Hartwell M. Associations of maternal age, education, and marital status with HPV vaccine uptake and hesitancy among united states youth: a cross-sectional analysis of the 2020 National Immunization Survey. J Pediatr Adolesc Gynecol. 2023;36(3):273-9. DOI: https://doi.org/10.1016/j.jpag.2023.01.213
Mabeya H, Menon S, Weyers S, Naanyu V, Mwaliko E, Kirop E, et al. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting. BMC Cancer. 2018;18(1):1-7. DOI: https://doi.org/10.1186/s12885-018-4382-x
Shitu BF, Atnafu DD, Agumas Y. Public School adolescents had increased odds of being willing to uptake HPV vaccinations owing to sociodemographic and healthcare access features in Bahir Dar City, Ethiopia. Biomed Res Int. 2023;2023. DOI: https://doi.org/10.1155/2023/2663815
Asgedom YS, Kebede TM, Seifu BL, Mare KU, Asmare ZA, Asebe HA, et al. Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis. Hum Vaccin Immunother. 2024;20(1):2326295. DOI: https://doi.org/10.1080/21645515.2024.2326295
Bitariho GK, Tuhebwe D, Tigaiza A, Nalugya A, Ssekamatte T, Kiwanuka SN. Knowledge, perceptions and uptake of human papilloma virus vaccine among adolescent girls in Kampala, Uganda; a mixed-methods school-based study. BMC Pediatr. 2023;23(1):368. DOI: https://doi.org/10.1186/s12887-023-04174-z
Beyen MW, Bulto GA, Chaka EE, Debelo BT, Roga EY, Wakgari N, et al. Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020. PLoS One. 2022;17(7):e0271237. DOI: https://doi.org/10.1371/journal.pone.0271237
Downloads
Published
How to Cite
Issue
Section
